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Variant Creutzfeldt–Jakob Disease in a Patient  
with Heterozygosity at PRNP Codon 129
To the Editor: Prions cause lethal neurodegen-
erative diseases in mammals and are composed 
of multichain assemblies of misfolded host-
encoded cellular prion protein (PrP). A common 
polymorphism at codon 129 of the PrP gene 
(PRNP), where either methionine (M) or valine 
(V) is encoded, affects the susceptibility to prion 
disease, as well as the incubation period1 and 
clinical phenotype of prion disease. Human in-
fection with the epizootic prion disease bovine 
spongiform encephalopathy resulted in variant 
Creutzfeldt–Jakob disease, which provoked a 
public health crisis in the United Kingdom and 
other regions. All definite cases of variant 
Creutzfeldt–Jakob disease to date have occurred 
in patients with the MM genotype at PRNP co-
don 129.1
A 36-year-old man was referred to the United 
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Kingdom National Prion Clinic in August 2015 
with personality change. Over a period of 
9 months, he had become uncharacteristically 
irascible and had progressive episodic memory 
impairment, gait ataxia, and myoclonus. His 
score on the Mini–Mental State Examination 
was 25 (with scores ranging from 0 to 30 and 
higher scores indicating less impairment); clini-
cal examination revealed extraocular eye-move-
ment abnormalities, pyramidal and cerebellar 
signs, and multifocal myoclonus. Magnetic reso-
nance imaging of the brain (Fig. 1) revealed re-
stricted diffusion in the basal ganglia, hypothal-
ami, insular cortexes, and medial thalami but 
not in the pulvinar nuclei.2 Examination of the 
cerebrospinal fluid for protein 14-3-3 was nega-
Figure 1. MRI of the Brain.
Trace-weighted diffusion-weighted images (Panels A, B, and C) show high signal intensity in the basal ganglia, hypo-
thalami, and medial thalami but not in the pulvinar nuclei. These structures appear dark on the apparent diffusion 
coefficient map (Panel D), thus confirming the presence of restricted diffusion.
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tive, as was a real-time quaking-induced conver-
sion assay, although these two tests are known 
to have low sensitivity for variant Creutzfeldt–
Jakob disease.3 His genotype at PRNP codon 129 
was MV. During the following 6 months, the 
patient’s condition declined progressively, and 
severe dysphagia and agitation occurred shortly 
before his death in February 2016.
At autopsy, histologic examination of the brain 
revealed frequent florid and cluster plaques in 
cerebral and cerebellar cortexes, microvacuolar 
degeneration in neuropil, and immunostaining 
for abnormal PrP in a stellate pericellular and 
perivascular distribution. Minute amounts of 
protease-resistant PrP (PrPSc) were seen in lym-
phoid tissue of the spleen. Immunoblotting of 
brain homogenate revealed type 4 PrPSc (accord-
ing to the London classification system), which 
is pathognomonic of variant Creutzfeldt–Jakob 
disease.4 (For more details, see the Supplemen-
tary Appendix, available with the full text of this 
letter at NEJM.org.)
This patient’s clinical features differed from 
those of typical variant Creutzfeldt–Jakob dis-
ease, and his neuroimaging features suggested a 
diagnosis of sporadic Creutzfeldt–Jakob disease. 
He did not meet the epidemiologic diagnostic 
criteria for probable or possible variant Creutz-
feldt–Jakob disease,5 yet the results of the neuro-
pathological examination and molecular strain 
typing were consistent with variant Creutzfeldt–
Jakob disease. It remains uncertain whether this 
case marks the start of a second wave of variant 
Creutzfeldt–Jakob disease in persons with the 
MV genotype at PRNP codon 129 (the most com-
mon genotype in the United Kingdom), mirror-
ing the long incubation periods seen in persons 
with the MV genotype who have other acquired 
prion diseases, notably kuru.1 This case empha-
sizes the importance of performing an autopsy 
and molecular strain typing in cases of prion 
disease to ascertain the prevalence of human 
prion disease related to bovine spongiform en-
cephalopathy.
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